Purple Biotech Ltd
PPBT
$1.50
$0.010.33%
NASDAQ
| 06/30/2026 | 12/31/2025 | 06/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Net Income | -- | -- | -2.61M | -3.93M | |
| Total Depreciation and Amortization | -- | -- | 181.00K | 183.00K | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | -- | -- | -2.93M | -3.40M | |
| Change in Net Operating Assets | -- | -- | -3.47M | -4.11M | |
| Cash from Operations | -- | -- | -8.83M | -11.26M | |
| Capital Expenditure | -- | -- | -2.00K | -- | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | -- | 476.00K | 454.00K | |
| Cash from Investing | -- | -- | 474.00K | 454.00K | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -184.00K | -191.00K | |
| Issuance of Common Stock | -- | -- | 7.56M | 7.68M | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -837.00K | -884.00K | |
| Cash from Financing | -- | -- | 6.54M | 6.61M | |
| Foreign Exchange rate Adjustments | -- | -- | 27.00K | -13.00K | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -- | -- | -1.79M | -4.21M | |